Bayer, Amgen join $ 120M financing for startup aiming to expand genetic meds delivery
ReCode Therapeutics was formed around new science potentially enabling delivery of genetic medicines to various organs in the body, and the startup has encouraging data for its therapeutic candidates targeting the lungs. Now the biotech startup has $ 120 million to show that it can deliver on the technology’s promise in other organs and cell … Read more